HomeCompareAVDE vs JNJ

AVDE vs JNJ: Dividend Comparison 2026

AVDE yields 2.71% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVDE wins by $3.7K in total portfolio value
10 years
AVDE
AVDE
● Live price
2.71%
Share price
$84.52
Annual div
$2.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.7K
Annual income
$322.44
Full AVDE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AVDE vs JNJ

📍 AVDE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVDEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVDE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVDE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVDE
Annual income on $10K today (after 15% tax)
$230.15/yr
After 10yr DRIP, annual income (after tax)
$274.07/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $429.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVDE + JNJ for your $10,000?

AVDE: 50%JNJ: 50%
100% JNJ50/50100% AVDE
Portfolio after 10yr
$21.9K
Annual income
$575.11/yr
Blended yield
2.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AVDE
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVDE buys
0
JNJ buys
0
No recent congressional trades found for AVDE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVDEJNJ
Forward yield2.71%3.36%
Annual dividend / share$2.29$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.7K$20.0K
Annual income after 10y$322.44$827.78
Total dividends collected$3.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AVDE vs JNJ ($10,000, DRIP)

YearAVDE PortfolioAVDE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,971$270.77$10,676$355.77+$295.00AVDE
2$12,016$277.62$11,407$389.39+$609.00AVDE
3$13,142$284.19$12,198$426.53+$944.00AVDE
4$14,352$290.47$13,056$467.62+$1.3KAVDE
5$15,653$296.47$13,987$513.12+$1.7KAVDE
6$17,051$302.19$14,998$563.56+$2.1KAVDE
7$18,552$307.64$16,098$619.52+$2.5KAVDE
8$20,164$312.83$17,295$681.69+$2.9KAVDE
9$21,893$317.76$18,599$750.82+$3.3KAVDE
10$23,748$322.44$20,022$827.78+$3.7KAVDE

AVDE vs JNJ: Complete Analysis 2026

AVDEStock

Invests in a broad set of companies of all market capitalizations across non-U.S. developed countries and is designed to increase expected returns by overweighting securities we believe to be trading at lower valuations with higher profitability ratios.Pursues the benefits associated with indexing (diversification, low turnover, transparency of exposures), but with the ability to add value by making investment decisions using information in current prices.Efficient portfolio management and trading process that is designed to enhance returns while seeking to reduce unnecessary risks and costs.Built to fit seamlessly into an investor's asset allocation.

Full AVDE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AVDE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVDE vs SCHDAVDE vs JEPIAVDE vs OAVDE vs KOAVDE vs MAINAVDE vs ABBVAVDE vs MRKAVDE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.